Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guangzhou Nanxin Pharmaceutical is a Chinese pharmaceutical company headquartered in Guangzhou, specializing in the development and manufacturing of chemical drugs and traditional Chinese patent medicines. Established in 2003, the company has built a robust portfolio of over-the-counter and prescription products, particularly in the respiratory, analgesic, and anti-infective therapeutic areas. Its flagship products include Compound Paracetamol and Amantadine Hydrochloride capsules and Ibuprofen sustained-release formulations. The company operates large-scale, GMP-certified manufacturing facilities in the Liangtian Industrial Park, producing various dosage forms such as tablets, capsules, and granules. Nanxin Pharmaceutical is recognized as a high-tech enterprise within Guangdong Province, serving a wide network of hospitals and retail pharmacies across China.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 广州南鑫药业.